AFIBROMER Trademark

Trademark Overview

On Wednesday, June 28, 2017, a trademark application was filed for AFIBROMER with the United States Patent and Trademark Office. The USPTO has given the AFIBROMER trademark a serial number of 87508729. The federal status of this trademark filing is REGISTERED as of Tuesday, May 26, 2020. This trademark is owned by Sigilon Therapeutics, Inc.. The AFIBROMER trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Chemical, pharmaceutical, biopharmaceutical and biomedical agents for medical use, namely, agents for medical use, in the nature of agents which mitigate the foreign body response; chemical agents for pharmaceutical or medical purposes, namely, agents that mitigate the foreign body response; pharmaceutical agents for encapsulating transplanted cells to prevent the risk of rejection from immune attack, for medical purposes; pharmaceutical preparations for the prevention and treatment of fibrosis, inflammation, cancer and infection; drug delivery agents in the form of coatings for capsules that facilitate the tolerance and delivery of pharmaceutical preparations; Chemical agents, namely, drug delivery agents for encapsulating pharmaceutical agents and cells that facilitate the delivery of a wide range of pharmaceuticals

Chemical agents for scientific and research use, namely, small molecules in the nature of chemical preparations
afibromer

General Information

Serial Number87508729
Word MarkAFIBROMER
Filing DateWednesday, June 28, 2017
Status700 - REGISTERED
Status DateTuesday, May 26, 2020
Registration Number6064583
Registration DateTuesday, May 26, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 6, 2018

Trademark Statements

Goods and ServicesChemical, pharmaceutical, biopharmaceutical and biomedical agents for medical use, namely, agents for medical use, in the nature of agents which mitigate the foreign body response; chemical agents for pharmaceutical or medical purposes, namely, agents that mitigate the foreign body response; pharmaceutical agents for encapsulating transplanted cells to prevent the risk of rejection from immune attack, for medical purposes; pharmaceutical preparations for the prevention and treatment of fibrosis, inflammation, cancer and infection; drug delivery agents in the form of coatings for capsules that facilitate the tolerance and delivery of pharmaceutical preparations; Chemical agents, namely, drug delivery agents for encapsulating pharmaceutical agents and cells that facilitate the delivery of a wide range of pharmaceuticals
Goods and ServicesChemical agents for scientific and research use, namely, small molecules in the nature of chemical preparations

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, July 6, 2017
Primary Code001
First Use Anywhere DateTuesday, January 30, 2018
First Use In Commerce DateTuesday, January 30, 2018
International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 6, 2017
Primary Code005
First Use Anywhere DateTuesday, December 5, 2017
First Use In Commerce DateTuesday, December 5, 2017

Trademark Owner History

Party NameSigilon Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameSigilon Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameSigilon Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Monday, March 18, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 18, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 18, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 18, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 18, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, May 26, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, April 21, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Saturday, April 18, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, April 8, 2020STATEMENT OF USE PROCESSING COMPLETE
Monday, March 23, 2020USE AMENDMENT FILED
Wednesday, April 8, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 23, 2020TEAS STATEMENT OF USE RECEIVED
Tuesday, December 24, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 20, 2019SOU EXTENSION 2 GRANTED
Friday, December 20, 2019SOU EXTENSION 2 FILED
Friday, December 20, 2019SOU TEAS EXTENSION RECEIVED
Friday, June 28, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 26, 2019SOU EXTENSION 1 GRANTED
Wednesday, June 26, 2019SOU EXTENSION 1 FILED
Wednesday, June 26, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, January 1, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, December 21, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 21, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 6, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 6, 2018PUBLISHED FOR OPPOSITION
Wednesday, October 17, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 25, 2018ASSIGNED TO LIE
Wednesday, September 12, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 6, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, September 6, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, September 6, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 5, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 5, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 22, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, March 22, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 7, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 7, 2018NON-FINAL ACTION E-MAILED
Wednesday, March 7, 2018NON-FINAL ACTION WRITTEN
Wednesday, February 14, 2018EXAMINER'S AMENDMENT ENTERED
Wednesday, February 14, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, February 14, 2018EXAMINERS AMENDMENT E-MAILED
Wednesday, February 14, 2018EXAMINERS AMENDMENT -WRITTEN
Thursday, January 11, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 11, 2018NON-FINAL ACTION E-MAILED
Thursday, January 11, 2018NON-FINAL ACTION WRITTEN
Thursday, December 21, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 20, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 20, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 3, 2017NOTIFICATION OF PRIORITY ACTION E-MAILED
Tuesday, October 3, 2017PRIORITY ACTION E-MAILED
Tuesday, October 3, 2017PRIORITY ACTION WRITTEN
Tuesday, September 26, 2017ASSIGNED TO EXAMINER
Thursday, July 6, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, July 1, 2017NEW APPLICATION ENTERED

Related Keywords

afibromer agents pharmaceutical chemical namely medical delivery preparations purposes cells facilitate